Literature DB >> 6542055

Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine.

E E Creppy, R Röschenthaler, G Dirheimer.   

Abstract

The sensitivity of protein synthesis to ip doses of ochratoxin A ranging from 1 to 15 mg/kg body weight has been determined in the livers, kidneys and spleens of mice. The incorporation of 14C-labelled amino acids into protein was measured in the total tissue homogenate, in the 105,000-g supernatant fraction and in the fraction of thermostable soluble proteins. The inhibition of protein synthesis was greatest in spleen and kidney and least in liver. The percentage inhibition of protein synthesis by any one dose of ochratoxin A was similar in all of the protein fractions from any one organ. The degree of inhibition of protein synthesis 5 hr after administration of 1 mg ochratoxin A/kg was 26% in liver, 68% in kidney and 75% in spleen. Phenylalanine (100 mg/kg) injected together with ochratoxin A prevented the inhibition of protein synthesis by a dose of 10 mg OTA/kg in all of these organs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542055     DOI: 10.1016/0278-6915(84)90170-4

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  17 in total

1.  Activation markers and cell proliferation as indicators of toxicity: a flow cytometric approach.

Authors:  A Johannisson; A Thuvander; I L Gadhasson
Journal:  Cell Biol Toxicol       Date:  1995-12       Impact factor: 6.691

2.  Microphysiological system modeling of ochratoxin A-associated nephrotoxicity.

Authors:  Tomoki Imaoka; Jade Yang; Lu Wang; Matthew G McDonald; Zahra Afsharinejad; Theo K Bammler; Kirk Van Ness; Catherine K Yeung; Allan E Rettie; Jonathan Himmelfarb; Edward J Kelly
Journal:  Toxicology       Date:  2020-09-06       Impact factor: 4.221

3.  The myocotoxin ochratoxin A is a substrate for phenylalanine hydroxylase in isolated rat hepatocytes and in vivo.

Authors:  E E Creppy; K Chakor; M J Fisher; G Dirheimer
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

Review 4.  Xenobiotic transporters and kidney injury.

Authors:  Blessy George; Dahea You; Melanie S Joy; Lauren M Aleksunes
Journal:  Adv Drug Deliv Rev       Date:  2017-01-20       Impact factor: 15.470

Review 5.  New Evidences about the Carcinogenic Effects of Ochratoxin A and Possible Prevention by Target Feed Additives.

Authors:  Stoycho D Stoev
Journal:  Toxins (Basel)       Date:  2022-05-30       Impact factor: 5.075

6.  Complex etiology and pathology of mycotoxic nephropathy in South African pigs.

Authors:  Stoycho D Stoev; Stefan Denev; Mike F Dutton; Patrick B Njobeh; Joseph S Mosonik; Paul A Steenkamp; Iordan Petkov
Journal:  Mycotoxin Res       Date:  2009-11-17       Impact factor: 3.833

7.  Distribution of the [3H]-label from low doses of radioactive ochratoxin A ingested by rats, and evidence for DNA single-strand breaks caused in liver and kidneys.

Authors:  A Kane; E E Creppy; A Roth; R Röschenthaler; G Dirheimer
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

8.  Ochratoxin A impairs "postproximal" nephron function in vivo and blocks plasma membrane anion conductance in Madin-Darby canine kidney cells in vitro.

Authors:  M Gekle; H Oberleithner; S Silbernagl
Journal:  Pflugers Arch       Date:  1993-12       Impact factor: 3.657

9.  Studies on carcinogenic and toxic effects of ochratoxin A in chicks.

Authors:  Stoycho D Stoev
Journal:  Toxins (Basel)       Date:  2010-04-12       Impact factor: 4.546

10.  Complex etiology, prophylaxis and hygiene control in mycotoxic nephropathies in farm animals and humans.

Authors:  Stoycho D Stoev
Journal:  Int J Mol Sci       Date:  2008-04-18       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.